WallStreetZenWallStreetZen

NASDAQ: DAWN
Day One Biopharmaceuticals Inc Stock Ownership - Who owns Day One Biopharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Day One Biopharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Samuel C. BlackmanHEAD OF RD2024-12-1030,000$13.31
$399.33kSell
Jeremy BenderCHIEF EXECUTIVE OFFICER2024-11-1810,554$13.21
$139.42kSell
Charles N. York IiCOO CFO AND SECRETARY2024-11-182,602$13.21
$34.37kSell
Adam DubowGENERAL COUNSEL2024-11-183,165$13.21
$41.81kSell
Samuel C. BlackmanHEAD OF RD2024-11-182,206$13.21
$29.14kSell
Samuel C. BlackmanHEAD OF RD2024-11-1110,000$16.10
$160.99kSell
Samuel C. BlackmanHEAD OF RD2024-11-0818,255$16.17
$295.22kSell
Samuel C. BlackmanHEAD OF RD2024-11-0711,245$16.03
$180.29kSell
Samuel C. BlackmanHEAD OF RD2024-10-31500$16.02
$8.01kSell
Samuel C. BlackmanHEAD OF RD2024-09-1030,000$14.22
$426.69kSell

1 of 4

DAWN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DAWN insiders and whales buy or sell their stock.

DAWN Shareholders

What type of owners hold Day One Biopharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ai Day1 LLC12.82%12,929,322$144.29MInsider
Papanek Julie Grant11.11%11,199,207$124.98MInsider
Ai Day 1 LLC9.30%9,377,776$104.66MInsider
Ra Capital Management LP7.81%7,871,721$87.85MInstitution
Fmr LLC7.35%7,412,380$82.72MInstitution
Canaan XI LP6.91%6,964,301$77.72MInsider
Atlas Venture Life Science Advisors LLC6.38%6,430,257$71.76MInstitution
Atlas Venture Fund XI LP6.21%6,258,534$69.85MInsider
Takeda Pharmaceutical Co Ltd6.07%6,120,124$68.30MInsider
Vanguard Group Inc5.84%5,887,210$65.70MInstitution

1 of 3

DAWN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DAWN58.94%41.06%Net SellingNet Selling
ARVN76.33%23.67%Net SellingNet Selling
SPRY41.47%58.53%Net SellingNet Selling
MRVI48.86%51.14%Net SellingNet Buying
INVA58.63%41.37%Net BuyingNet Selling
View Top Biotech Stocks

Day One Biopharmaceuticals Stock Ownership FAQ

Who owns Day One Biopharmaceuticals?

Day One Biopharmaceuticals (NASDAQ: DAWN) is owned by 90.99% institutional shareholders, 63.38% Day One Biopharmaceuticals insiders, and 0.00% retail investors. Ai Day1 LLC is the largest individual Day One Biopharmaceuticals shareholder, owning 12.93M shares representing 12.82% of the company. Ai Day1 LLC's Day One Biopharmaceuticals shares are currently valued at $153.47M.

If you're new to stock investing, here's how to buy Day One Biopharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.